Kayla Visit 1: A 28-year-old Woman Presenting with Vision Problems That May Indicate Multiple Sclerosis

Title:

Kayla Visit 1: A 28-year-old Woman Presenting with Vision Problems That May Indicate Multiple Sclerosis

Topic: Neurology
Relevant Terms: Multiple Sclerosis
Primary Audience: Neurologists and other clinicians who care for patients with MS
Launch Date: 07-Jan-14
Credits: 0.5 AMA PRA Category 1 Credit
Expiration Date: 06-Jan-15
Curriculum Name: Patient-Centered Approaches in the Continuum of Multiple Sclerosis Care

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Explain the rationale and current evidence for early use of disease-modifying therapy in patients with MS.
  2. Translate rationale and current evidence for early use of disease-modifying therapy into information that can be relayed to patients with MS.
  3. Develop first-line disease-modifying treatment regimens for patients with relapsing-remitting MS based on the latest clinical trial evidence.

    Faculty

    Ben Thrower, MD
    Clinical Instructor of Neurology
    Emory University
    Medical Director
    Andrew C. Carlos Multiple Sclerosis Institute
    Shepherd Center
    Atlanta, GA
    Neil S. Lava, MD
    Professor of Neurology
    Director, Multiple Sclerosis Clinic
    Emory University
    Atlanta, GA
    J. Theodore Phillips, MD, PhD, FAAN
    Clinical Professor
    Department of Neurology
    University of Texas Southwestern Medical Center
    Research Investigator
    Multiple Sclerosis Research Program|
    Baylor Institute for Immunology Research
    Dallas, TX
    PLANNERS AND REVIEWERS DISCLOSURE
    Ben Thrower, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Acorda Therapeutics; Biogen Idec, Inc.; Genzyme Corporation; Teva Neuroscience, Inc.
    Served as a speaker or a member of a speakers bureau for: Acorda Therapeutics; Biogen Idec, Inc.; Genzyme Corporation; Teva Neuroscience, Inc.

    Neil Lava, MD, has no conflicts of interest to disclose.

    J. Theodore Phillips, MD, has disclosed the following relevant financial relationships:
    Received grant support from: Roche.
    Served as a speaker or a member of a speakers bureau for: Acorda Therapeutics; Biogen Idec, Inc.; Genzyme; and Sanofi.

    Rick Ricer, MD, physician reviewer, has no conflicts of interest to disclose.
    Susan P. Tyler, MEd, CCMEP, FACEHP, has no conflicts of interest to disclose.
    Joshua Kilbridge, medical writer, has no conflicts of interest to disclose.
    Kathleen Hines, MCM Education editorial director, has no conflicts of interest to disclose.

    DISCLAIMER
    The opinions or views expressed in this CME activity are those of the presenters and do not necessarily reflect the opinions or recommendations of the University of Cincinnati, MCM Education, or the commercial supporter(s). Participants should critically appraise the information presented and are encouraged to consult appropriate resources for information surrounding any product, device, or procedure mentioned.

    ACCREDITATION STATEMENT 
    This activity has been planned and implemented in accordance with the Essentials Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Cincinnati and MCM Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
     
    CREDIT DESIGNATION
    The University of Cincinnati designates this Enduring Material Activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



    University of Cincinnati
    Continuing Medical Education
    College of Medicine
    3225 Eden Avenue, G24 Wherry Hall
    Cincinnati, OH 45267
    Email: uccme@uc.edu
     
    Release Date: January 7, 2014
    Expiration Date: January 6, 2015

    TERM OF OFFERING
    This activity has a release date of January 7, 2014 and is valid for 1 year. Requests for credit must be received no later than January 6, 2015.

    CREDIT DETERMINATION
    A review committee has agreed that this material can be completed in 30 minutes. This estimated study time in turn has determined the credit hours being offered.

    INSTRUCTIONS FOR PARTICIPATING IN THIS ACTIVITY AND OBTAINING CME CREDIT
    There are no fees for participating in and receiving CME credit for this online educational activity. By reviewing the course content and successfully completing the post-test and evaluation, clinicians are entitled to receive credit. The statement of credit will be available to print from your user history page.
    • Read the learning objectives and faculty disclosures
    • Participate in the activity
    • Complete the post-test and activity evaluation
    • Clinicians who successfully complete the post-test and evaluation will receive a CME certificate; successful completion is defined as a cumulative score of at least 60% correct
    • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation
      
    ESTIMATED TIME TO COMPLETE 
    30 minutes

    COMMERCIAL SUPPORT

    This activity is supported by an independent educational grant from Teva Neuroscience.

    Commercial Support Guidelines
    If any activity is supported by funds from a commercial source such as a pharmaceutical company or an equipment manufacturer it is very important that the Standards for Commercial Support are followed. In general, commercial entities may support CME activities through unrestricted grants. A commercial supporter may not exert undue influence in the form of determining content, choosing speakers, directly paying honoraria to faculty or paying registration fees of attendees. An acknowledgement of any educational support from a commercial company must appear in program brochures, syllabi, and other program materials.
     
    COURSE VIEWING REQUIREMENTS
    Supported Browsers:
    Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
    Google Chrome 28.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
    Safari 5.0+ for Mac OSX 10.5 and above

    For video playback, install the latest version of Flash or Quicktime.
    Supported Phones & Tablets:
    Android 4.0.3 and above
    iPhone/iPad with iOS 6.1 or above